Choosing the most appropriate clone is a serious task for clinical laboratory staff, since a comparative study (41) on lung cancer samples implies that different clones have different performances and for different products, their specific clones of PD-L1 is required, which makes the process complicated. Here, CD274 is linked to lung carcinoma.